Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Paradela-Dobarro B, Grigorian-Shamagian L, García-Acuña JM, Aguiar-Souto P, Jacquet-Hervet M, Reino-Maceiras MV, González-Juanatey JR, Álvarez E. Raposeiras-Roubín S, et al. Among authors: aguiar souto p. PLoS One. 2013 Sep 13;8(9):e74302. doi: 10.1371/journal.pone.0074302. eCollection 2013. PLoS One. 2013. PMID: 24058542 Free PMC article.
Statins modulate feedback regulation mechanisms between advanced glycation end-products and C-reactive protein: evidence in patients with acute myocardial infarction.
Paradela-Dobarro B, Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, García-Acuña JM, Aguiar-Souto P, Jacquet-Hervet M, Reino-Maceiras MV, González-Juanatey JR, Alvarez E. Paradela-Dobarro B, et al. Among authors: aguiar souto p. Eur J Pharm Sci. 2013 Jul 16;49(4):512-8. doi: 10.1016/j.ejps.2013.05.001. Epub 2013 May 9. Eur J Pharm Sci. 2013. PMID: 23665412
High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
Raposeiras Roubín S, Barreiro Pardal C, Roubín-Camiña F, Ocaranza Sanchez R, Alvarez Castro E, Paradela Dobarro B, García-Acuña JM, Aguiar Souto P, Jacquet Hervet M, Castromán MJ, Arufe I, Outes B, Reino-Maceiras MV, Abu Assi E, González-Juanatey JR. Raposeiras Roubín S, et al. Among authors: aguiar souto p. Rev Port Cardiol. 2013 Feb;32(2):117-22. doi: 10.1016/j.repc.2012.05.026. Epub 2013 Jan 20. Rev Port Cardiol. 2013. PMID: 23337430 Free article.
Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Paradela-Dobarro B, Grigorian-Shamagian L, García-Acuña JM, Aguiar-Souto P, Jacquet-Hervet M, Reino-Maceiras MV, Alvarez E, González-Juanatey JR. Raposeiras-Roubín S, et al. Among authors: aguiar souto p. Cardiovasc Diabetol. 2012 Aug 21;11:102. doi: 10.1186/1475-2840-11-102. Cardiovasc Diabetol. 2012. PMID: 22909322 Free PMC article.
GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function.
Raposeiras-Roubín S, Aguiar-Souto P, Barreiro-Pardal C, López Otero D, Elices Teja J, Ocaranza Sanchez R, Cid Alvarez B, Trillo Nouche R, Maceiras MV, Abu-Assi E, García-Acuña JM, González-Juanatey JR. Raposeiras-Roubín S, et al. Among authors: aguiar souto p. Angiology. 2013 Jan;64(1):31-9. doi: 10.1177/0003319711434800. Epub 2012 Feb 1. Angiology. 2013. PMID: 22297037
25 results